P-CREB expression in human gliomas

Potential use in the differential diagnosis between astrocytoma and oligodendroglioma

Valeria Barresi, Stefania Mondello, Giovanni Branca, Thangavelu Soundara Rajan, Enrica Vitarelli, Giovanni Tuccari

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Phosphorylated cyclic-AMP responsive element binding protein (p-CREB) is a transcription factor that is involved in gliomagenesis. For this reason, it was recently proposed as a potential therapeutic target in gliomas; however, gliomas comprise tumors with different biomolecular profile, clinical behavior, and response to chemotherapy. In the present study, we aimed to investigate whether p-CREB expression varies in the 2 main types of gliomas, astrocytomas and oligodendrogliomas. Thus, we analyzed the expression of p-CREB in a series of astrocytomas and oligodendrogliomas of different histologic grades by immunohistochemistry and Western blot analysis. p53 overexpression and the Ki-67 labeling index were also assessed in all the tumors. p-CREB immunohistochemical expression was present in 100% of the astrocytic tumors, but in only 46% of oligodendrogliomas (P =.0033 for grade II; P =.0041 for grade III tumors). Absence of p-CREB immunohistochemical expression was significantly associated with 1p/19q codeletion (P

Original languageEnglish
Pages (from-to)231-238
Number of pages8
JournalHuman Pathology
Volume46
Issue number2
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Oligodendroglioma
Astrocytoma
Glioma
Cyclic AMP
Carrier Proteins
Differential Diagnosis
Neoplasms
Transcription Factors
Western Blotting
Immunohistochemistry
Drug Therapy

Keywords

  • 1p/19q codeletion
  • Astrocytoma
  • Oligodendroglioma
  • p-CREB
  • p53

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

P-CREB expression in human gliomas : Potential use in the differential diagnosis between astrocytoma and oligodendroglioma. / Barresi, Valeria; Mondello, Stefania; Branca, Giovanni; Rajan, Thangavelu Soundara; Vitarelli, Enrica; Tuccari, Giovanni.

In: Human Pathology, Vol. 46, No. 2, 01.02.2015, p. 231-238.

Research output: Contribution to journalArticle

Barresi, Valeria ; Mondello, Stefania ; Branca, Giovanni ; Rajan, Thangavelu Soundara ; Vitarelli, Enrica ; Tuccari, Giovanni. / P-CREB expression in human gliomas : Potential use in the differential diagnosis between astrocytoma and oligodendroglioma. In: Human Pathology. 2015 ; Vol. 46, No. 2. pp. 231-238.
@article{b5958e16c83a4b619c5716bb975f32ff,
title = "P-CREB expression in human gliomas: Potential use in the differential diagnosis between astrocytoma and oligodendroglioma",
abstract = "Phosphorylated cyclic-AMP responsive element binding protein (p-CREB) is a transcription factor that is involved in gliomagenesis. For this reason, it was recently proposed as a potential therapeutic target in gliomas; however, gliomas comprise tumors with different biomolecular profile, clinical behavior, and response to chemotherapy. In the present study, we aimed to investigate whether p-CREB expression varies in the 2 main types of gliomas, astrocytomas and oligodendrogliomas. Thus, we analyzed the expression of p-CREB in a series of astrocytomas and oligodendrogliomas of different histologic grades by immunohistochemistry and Western blot analysis. p53 overexpression and the Ki-67 labeling index were also assessed in all the tumors. p-CREB immunohistochemical expression was present in 100{\%} of the astrocytic tumors, but in only 46{\%} of oligodendrogliomas (P =.0033 for grade II; P =.0041 for grade III tumors). Absence of p-CREB immunohistochemical expression was significantly associated with 1p/19q codeletion (P",
keywords = "1p/19q codeletion, Astrocytoma, Oligodendroglioma, p-CREB, p53",
author = "Valeria Barresi and Stefania Mondello and Giovanni Branca and Rajan, {Thangavelu Soundara} and Enrica Vitarelli and Giovanni Tuccari",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.humpath.2014.10.011",
language = "English",
volume = "46",
pages = "231--238",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - P-CREB expression in human gliomas

T2 - Potential use in the differential diagnosis between astrocytoma and oligodendroglioma

AU - Barresi, Valeria

AU - Mondello, Stefania

AU - Branca, Giovanni

AU - Rajan, Thangavelu Soundara

AU - Vitarelli, Enrica

AU - Tuccari, Giovanni

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Phosphorylated cyclic-AMP responsive element binding protein (p-CREB) is a transcription factor that is involved in gliomagenesis. For this reason, it was recently proposed as a potential therapeutic target in gliomas; however, gliomas comprise tumors with different biomolecular profile, clinical behavior, and response to chemotherapy. In the present study, we aimed to investigate whether p-CREB expression varies in the 2 main types of gliomas, astrocytomas and oligodendrogliomas. Thus, we analyzed the expression of p-CREB in a series of astrocytomas and oligodendrogliomas of different histologic grades by immunohistochemistry and Western blot analysis. p53 overexpression and the Ki-67 labeling index were also assessed in all the tumors. p-CREB immunohistochemical expression was present in 100% of the astrocytic tumors, but in only 46% of oligodendrogliomas (P =.0033 for grade II; P =.0041 for grade III tumors). Absence of p-CREB immunohistochemical expression was significantly associated with 1p/19q codeletion (P

AB - Phosphorylated cyclic-AMP responsive element binding protein (p-CREB) is a transcription factor that is involved in gliomagenesis. For this reason, it was recently proposed as a potential therapeutic target in gliomas; however, gliomas comprise tumors with different biomolecular profile, clinical behavior, and response to chemotherapy. In the present study, we aimed to investigate whether p-CREB expression varies in the 2 main types of gliomas, astrocytomas and oligodendrogliomas. Thus, we analyzed the expression of p-CREB in a series of astrocytomas and oligodendrogliomas of different histologic grades by immunohistochemistry and Western blot analysis. p53 overexpression and the Ki-67 labeling index were also assessed in all the tumors. p-CREB immunohistochemical expression was present in 100% of the astrocytic tumors, but in only 46% of oligodendrogliomas (P =.0033 for grade II; P =.0041 for grade III tumors). Absence of p-CREB immunohistochemical expression was significantly associated with 1p/19q codeletion (P

KW - 1p/19q codeletion

KW - Astrocytoma

KW - Oligodendroglioma

KW - p-CREB

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=84920928048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920928048&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2014.10.011

DO - 10.1016/j.humpath.2014.10.011

M3 - Article

VL - 46

SP - 231

EP - 238

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 2

ER -